A Single and Multiple Dose Study of AMAZ-02 to Evaluate Safety and Pharmacokinetics in Elderly Subjects

Clinical trial NCT02655393 · COMPLETED

Trial details

NCT number: NCT02655393
Sponsor: Amazentis SA
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Aging Mitochondrial Dysfunction Muscle Function

Start date: 2016-01-01
Primary completion: 2016-09-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.